Fabian Stimpfle

426 total citations
16 papers, 314 citations indexed

About

Fabian Stimpfle is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Fabian Stimpfle has authored 16 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 3 papers in Hematology. Recurrent topics in Fabian Stimpfle's work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Acute Myocardial Infarction Research (6 papers) and Coronary Interventions and Diagnostics (4 papers). Fabian Stimpfle is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Acute Myocardial Infarction Research (6 papers) and Coronary Interventions and Diagnostics (4 papers). Fabian Stimpfle collaborates with scholars based in Germany, Austria and Panama. Fabian Stimpfle's co-authors include Meinrad Gawaz, Tobias Geisler, Karin Müller, Martin Duckheim, Jürgen Schreieck, Matthias Schwab, Michal Droppa, Dominik Rath, Peter Seizer and Iris Müller and has published in prestigious journals such as PLoS ONE, Atherosclerosis and Thrombosis and Haemostasis.

In The Last Decade

Fabian Stimpfle

16 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabian Stimpfle Germany 10 214 58 52 43 31 16 314
Laura West United Kingdom 5 100 0.5× 40 0.7× 46 0.9× 26 0.6× 68 2.2× 7 234
Finn Åkerström Spain 13 320 1.5× 61 1.1× 59 1.1× 36 0.8× 49 1.6× 50 410
Iván Parra‐Izquierdo United States 11 141 0.7× 29 0.5× 90 1.7× 64 1.5× 66 2.1× 18 335
Marie-Blanche Onselaer United Kingdom 6 124 0.6× 55 0.9× 65 1.3× 26 0.6× 71 2.3× 8 310
Nader Joghetaei Germany 8 225 1.1× 59 1.0× 121 2.3× 29 0.7× 24 0.8× 10 385
Elisa Bertacco Italy 10 195 0.9× 56 1.0× 48 0.9× 72 1.7× 99 3.2× 12 344
Aurelio M. Sueiro Spain 10 110 0.5× 41 0.7× 221 4.3× 83 1.9× 12 0.4× 14 392
Delia I. Fernández Netherlands 8 46 0.2× 26 0.4× 45 0.9× 34 0.8× 34 1.1× 14 232
C.J.N. Verkleij Netherlands 7 59 0.3× 67 1.2× 88 1.7× 74 1.7× 37 1.2× 7 305
Benjamin E. J. Spurgeon United Kingdom 11 69 0.3× 32 0.6× 90 1.7× 18 0.4× 59 1.9× 23 309

Countries citing papers authored by Fabian Stimpfle

Since Specialization
Citations

This map shows the geographic impact of Fabian Stimpfle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabian Stimpfle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabian Stimpfle more than expected).

Fields of papers citing papers by Fabian Stimpfle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabian Stimpfle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabian Stimpfle. The network helps show where Fabian Stimpfle may publish in the future.

Co-authorship network of co-authors of Fabian Stimpfle

This figure shows the co-authorship network connecting the top 25 collaborators of Fabian Stimpfle. A scholar is included among the top collaborators of Fabian Stimpfle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabian Stimpfle. Fabian Stimpfle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Schaeffeler, Elke, Stefan Winter, Monika Zdanytė, et al.. (2021). C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease. Pharmacogenomics and Personalized Medicine. Volume 14. 893–903. 5 indexed citations
2.
Gramlich, Michael, Martin Duckheim, Fabian Stimpfle, et al.. (2019). Cryoballoon ablation for persistent atrial fibrillation in patients without left atrial fibrosis. Journal of Cardiovascular Electrophysiology. 30(7). 999–1004. 12 indexed citations
3.
Stimpfle, Fabian, Dominik Rath, Elke Schaeffeler, et al.. (2018). Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI. Frontiers in Pharmacology. 9. 490–490. 15 indexed citations
4.
Groß, Lisa, Dietmar Trenk, Claudius Jacobshagen, et al.. (2018). Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy. Thrombosis and Haemostasis. 118(9). 1656–1667. 20 indexed citations
5.
Zhou, Qifeng, Saskia N. I. von Ungern‐Sternberg, David Heinzmann, et al.. (2018). Circulating MicroRNA-21 Correlates With Left Atrial Low-Voltage Areas and Is Associated With Procedure Outcome in Patients Undergoing Atrial Fibrillation Ablation. Circulation Arrhythmia and Electrophysiology. 11(6). e006242–e006242. 50 indexed citations
6.
Stimpfle, Fabian, Karin Müller, Tobias Geisler, et al.. (2017). Thromboembolic Risk Reduction Via Transseptal Thrombus Aspiration in a Patient With Spontaneous Left Atrial Thrombus and Stroke. JACC: Cardiovascular Interventions. 10(6). e57–e59. 1 indexed citations
7.
Rath, Dominik, Elke Schaeffeler, Stefan Winter, et al.. (2017). GPla Polymorphisms Are Associated with Outcomes in Patients at High Cardiovascular Risk. Frontiers in Cardiovascular Medicine. 4. 52–52. 9 indexed citations
8.
Rath, Dominik, Elke Schaeffeler, Stefan Winter, et al.. (2016). SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease. PLoS ONE. 11(9). e0161933–e0161933. 9 indexed citations
9.
Rath, Dominik, Madhumita Chatterjee, Karin Müller, et al.. (2016). Platelet surface expression of SDF-1 is associated with clinical outcomes in the patients with cardiovascular disease. Platelets. 28(1). 34–39. 15 indexed citations
10.
Droppa, Michal, Karin Müller, Athanasios Karathanos, et al.. (2015). Evaluation of Clinical Risk Factors to Predict High On-Treatment Platelet Reactivity and Outcome in Patients with Stable Coronary Artery Disease (PREDICT-STABLE). PLoS ONE. 10(3). e0121620–e0121620. 31 indexed citations
11.
Poli, Sven, Jennifer Diedler, Florian Härtig, et al.. (2015). Insertable cardiac monitors after cryptogenic stroke – a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. European Journal of Neurology. 23(2). 375–381. 72 indexed citations
12.
Stimpfle, Fabian & Tobias Geisler. (2015). Impact of Tailored Anti-P2Y12 Therapies in Acute Coronary Syndromes. Pharmacogenomics. 16(5). 493–499. 5 indexed citations
13.
Rath, Dominik, Madhumita Chatterjee, Iris Müller, et al.. (2014). Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome. Atherosclerosis. 237(2). 754–759. 26 indexed citations
14.
Stimpfle, Fabian, Athanasios Karathanos, Michal Droppa, et al.. (2014). Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting. Thrombosis Research. 134(1). 105–110. 18 indexed citations
15.
Müller, Karin, Athanasios Karathanos, Fabian Stimpfle, et al.. (2013). Combination of high on-treatment platelet aggregation and low deaggregation better predicts long-term cardiovascular events in PCI patients under dual antiplatelet therapy. Platelets. 25(6). 439–446. 4 indexed citations
16.
Conrad, Sabine, et al.. (2009). RGMb controls aggregation and migration of Neogenin-positive cells in vitro and in vivo. Molecular and Cellular Neuroscience. 43(2). 222–231. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura West Breakdown of academic impact, for papers by Finn Åkerström Breakdown of academic impact, for papers by Iván Parra‐Izquierdo Breakdown of academic impact, for papers by Marie-Blanche Onselaer Breakdown of academic impact, for papers by Nader Joghetaei Breakdown of academic impact, for papers by Elisa Bertacco Breakdown of academic impact, for papers by Aurelio M. Sueiro Breakdown of academic impact, for papers by Delia I. Fernández Breakdown of academic impact, for papers by C.J.N. Verkleij Breakdown of academic impact, for papers by Benjamin E. J. Spurgeon
Rankless by CCL
2026